ArticleJournal of clinical immunology2021

Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

Donald C Vinh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.